Medium-vessel Vasculitis Presenting with Myalgia Following COVID-19 Moderna Vaccination

Coronavirus disease 2019 (COVID-19) vaccines have been delivered worldwide to prevent the spread of the disease, and almost all Japanese have received the mRNA vaccines “BNT162b2” (Pfizer-BioNTech) or “mRNA-1273” (Moderna). These vaccines have shown efficacy and safety with only minor adverse drug r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohmura, Shin-ichiro, Ohkubo, Yusuke, Ishihara, Ryuhei, Otsuki, Yoshiro, Miyamoto, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751726/
https://www.ncbi.nlm.nih.gov/pubmed/36070946
http://dx.doi.org/10.2169/internalmedicine.0293-22
_version_ 1784850542690828288
author Ohmura, Shin-ichiro
Ohkubo, Yusuke
Ishihara, Ryuhei
Otsuki, Yoshiro
Miyamoto, Toshiaki
author_facet Ohmura, Shin-ichiro
Ohkubo, Yusuke
Ishihara, Ryuhei
Otsuki, Yoshiro
Miyamoto, Toshiaki
author_sort Ohmura, Shin-ichiro
collection PubMed
description Coronavirus disease 2019 (COVID-19) vaccines have been delivered worldwide to prevent the spread of the disease, and almost all Japanese have received the mRNA vaccines “BNT162b2” (Pfizer-BioNTech) or “mRNA-1273” (Moderna). These vaccines have shown efficacy and safety with only minor adverse drug reactions. However, some patients develop severe adverse drug reactions, including autoimmune reactions. In addition, systemic vasculitis, mainly small-vessel vasculitis, following COVID-19 vaccination, has been reported. However, only a few investigators have reported medium-vessel vasculitis following vaccination. We herein report a case of medium-vessel vasculitis presenting with myalgia as the initial clinical manifestation following COVID-19 Moderna vaccination.
format Online
Article
Text
id pubmed-9751726
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-97517262022-12-22 Medium-vessel Vasculitis Presenting with Myalgia Following COVID-19 Moderna Vaccination Ohmura, Shin-ichiro Ohkubo, Yusuke Ishihara, Ryuhei Otsuki, Yoshiro Miyamoto, Toshiaki Intern Med Case Report Coronavirus disease 2019 (COVID-19) vaccines have been delivered worldwide to prevent the spread of the disease, and almost all Japanese have received the mRNA vaccines “BNT162b2” (Pfizer-BioNTech) or “mRNA-1273” (Moderna). These vaccines have shown efficacy and safety with only minor adverse drug reactions. However, some patients develop severe adverse drug reactions, including autoimmune reactions. In addition, systemic vasculitis, mainly small-vessel vasculitis, following COVID-19 vaccination, has been reported. However, only a few investigators have reported medium-vessel vasculitis following vaccination. We herein report a case of medium-vessel vasculitis presenting with myalgia as the initial clinical manifestation following COVID-19 Moderna vaccination. The Japanese Society of Internal Medicine 2022-09-06 2022-11-15 /pmc/articles/PMC9751726/ /pubmed/36070946 http://dx.doi.org/10.2169/internalmedicine.0293-22 Text en Copyright © 2022 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Ohmura, Shin-ichiro
Ohkubo, Yusuke
Ishihara, Ryuhei
Otsuki, Yoshiro
Miyamoto, Toshiaki
Medium-vessel Vasculitis Presenting with Myalgia Following COVID-19 Moderna Vaccination
title Medium-vessel Vasculitis Presenting with Myalgia Following COVID-19 Moderna Vaccination
title_full Medium-vessel Vasculitis Presenting with Myalgia Following COVID-19 Moderna Vaccination
title_fullStr Medium-vessel Vasculitis Presenting with Myalgia Following COVID-19 Moderna Vaccination
title_full_unstemmed Medium-vessel Vasculitis Presenting with Myalgia Following COVID-19 Moderna Vaccination
title_short Medium-vessel Vasculitis Presenting with Myalgia Following COVID-19 Moderna Vaccination
title_sort medium-vessel vasculitis presenting with myalgia following covid-19 moderna vaccination
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751726/
https://www.ncbi.nlm.nih.gov/pubmed/36070946
http://dx.doi.org/10.2169/internalmedicine.0293-22
work_keys_str_mv AT ohmurashinichiro mediumvesselvasculitispresentingwithmyalgiafollowingcovid19modernavaccination
AT ohkuboyusuke mediumvesselvasculitispresentingwithmyalgiafollowingcovid19modernavaccination
AT ishihararyuhei mediumvesselvasculitispresentingwithmyalgiafollowingcovid19modernavaccination
AT otsukiyoshiro mediumvesselvasculitispresentingwithmyalgiafollowingcovid19modernavaccination
AT miyamototoshiaki mediumvesselvasculitispresentingwithmyalgiafollowingcovid19modernavaccination

Ejemplares similares